The roles of several signature genes, including GPR115 (47), TCN1 (48), COL11A1 (49), RHOV (50), DKK1 (51), SLC34A2 (52), LGR5 (53), SOAT2 (54), and CDH17 (55), in the tumorigenesis of NSCLC have been well established, with some emerging as potential therapeutic targets. Here, CDH17 is linked to non-small cell lung carcinoma.